Compass Associates
Multi-award-winning recruitment consultancy dedicated to the independent Health, Social Care and Children's Services sectors.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
The UK’s largest asthma study using real-world data has confirmed a link between over-reliance on SABA inhalers (short-acting beta-2 bronchodilators, also referred to as rescue inhalers) and an increase in asthma exacerbations and asthma-related healthcare utilisation.